S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|BioCryst Pharmaceuticals Announces the Appointment of Lynne Powell as Chief Commercial Officer|
|BioCryst shares rally on positive opinion from Europe for angioedema drug|
|BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress|
|BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema|
|BioCryst Reports Third Quarter 2014 Financial Results|
|BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema|
|BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza|
|BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection|
|BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema|
|BioCryst to Announce Third Quarter 2014 Financial Results November 6|
Click above to view more mutual fund data and stats for bcrx - Biocryst Pharmaceuticals Inc.